Retail & Wholesale » Retail | Profarma Distribuidora de Produtos Farmaceuticos S/A

Profarma Distribuidora de Produtos Farmaceuticos S/A Ord | Balance Sheet

Fiscal year is January-December. All values BRL Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
69
187
281
206
193
229
Total Accounts Receivable
755
685
750
822
799
901
Inventories
483
469
598
650
630
803
Other Current Assets
14
12
20
27
31
20
Total Current Assets
1,320
1,354
1,648
1,704
1,654
1,953
Net Property, Plant & Equipment
45
53
75
112
136
129
Total Investments and Advances
43
120
94
104
96
49
Long-Term Note Receivable
18
33
13
14
7
7
Intangible Assets
309
258
428
725
682
671
Other Assets
34
-
12
5
10
9
Total Assets
1,779
1,828
2,282
2,712
2,619
2,890
ST Debt & Current Portion LT Debt
205
181
341
246
716
Accounts Payable
447
536
711
735
698
Income Tax Payable
47
1
1
5
60
Other Current Liabilities
26
65
134
170
103
Total Current Liabilities
726
783
1,188
1,157
1,577
Long-Term Debt
335
235
187
362
41
Provision for Risks & Charges
128
105
200
365
236
Deferred Taxes
9
5
29
20
16
Total Liabilities
1,207
1,139
1,614
1,953
1,874
Common Equity (Total)
573
689
668
759
746
Total Shareholders' Equity
573
689
668
759
746
Total Equity
572
689
668
759
746
Liabilities & Shareholders' Equity
1,779
1,828
2,282
2,712
2,619
Accumulated Minority Interest
2
-
-
-
-

About Profarma Distribuidora de Produtos Farmaceuticos

View Profile
Address
Avenida Ayrton Senna, 2.150
Rio de Janeiro Rio de Janeiro 22775
Brazil
Employees -
Website http://www.profarma.com.br
Updated 07/08/2019
Profarma Distribuidora de Produtos Farmaceuticos SA provides wholesale operations to pharmaceutical retailers, with the sale of medicines and health and beauty products. It provides business through the following segments: Pharmaceutical Distribution, Hospital and Specialties, and Retail. The Pharmaceutical Distribution segment is the core business and comprises wholesale operations to pharmaceutical retail, with the sale of medicines and personal care and beauty products.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.